ASN's Mission

To create a world without kidney diseases, the ASN Alliance for Kidney Health elevates care by educating and informing, driving breakthroughs and innovation, and advocating for policies that create transformative changes in kidney medicine throughout the world.

learn more

Contact ASN

1401 H St, NW, Ste 900, Washington, DC 20005

email@asn-online.org

202-640-4660

The Latest on X

Kidney Week

Abstract: SA-PO722

Etiology of Severe Hyponatremia in COVID-19 Patients Compared with Hyponatremia with Non-COVID-19 Patients by Urine Osmolarity and Sodium

Session Information

Category: Fluid, Electrolytes, and Acid-Base Disorders

  • 1102 Fluid, Electrolyte, and Acid-Base Disorders: Clinical

Authors

  • Pak, Isaac, Westchester Medical Center, Valhalla, New York, United States
  • Durosier Louis, Miniolla, Westchester Medical Center, Valhalla, New York, United States
  • Kore, Shruti, Westchester Medical Center, Valhalla, New York, United States
  • Beck, James, Westchester Medical Center, Valhalla, New York, United States
  • Coritsidis, George N., Westchester Medical Center, Valhalla, New York, United States
Background



Lung diseases are known to be associated with hyponatremia and the Syndrome of Inappropriate Antidiuretic Hormone (SIADH) . As COVID-19 cases surged during the pandemic, hyponatremia among COVID-19 cases were reported, suggesting an increase in the incidence of
SIADH .This study attempts to evaluate for potential causes of severe hyponatremia ( HN) prior and during the COVID-19 pandemic.

Methods



Single center, observational retrospective study comparing severe HN ( serum sodium 125 mEq/L or less) presenting to Westchester Medical Center Emergency room between 2019- 2022. Demographic variables, urine osmolarity (Uosm), urine sodium (UNa) were collected from EMR. COVID-19 infections were diagnosed by PCR. A total of 477 charts were reviewed. Patients were divided in two groups, severe HN without COVID-19 in the year of 2019 and those with COVID-19 between 2020 and 2022.

Results


38 patients presented with severe HN and COVID-19 compared to 105 Non- COVID-19 patients in 2019. Complete urinary measurements were found in 26 COVID-19 patients & 66 Non-COVID-19 patients. 16 out of 26 COVID-19 patients preented with concentrated urine, Uosm >300. In patient with Uosm >300 Osm/kgH20 and UNa >20 Meq/L, 31% were COVID-19 positive and 24% Non-COVID -19, In patient with Uosm >300 and UNa < 20, 31% were COVID-19 positive compared to 33% Non COVID-19. Of those presenting with dilute urine Uosm <300, 38% were COVID-19 patients & 42% were Non-COVID-19 patients.

Conclusion

Severe Hyponatremia among COVID-19 and Non COVID-19 patients did not show a significant difference in etiology when comparing predictors Uosm and UNa. Despite other reports suggesting a higher incidence of SIADH, this was not evident in our severe HN COVID-19 patients.